Multiomic Evidence for a Unified Model of Alzheimer's Disease Etiology Linking Microglial Flux Capacity and Astrocyte-Neuron Metabolic Breakdown
Abstract
Age and APOE genotype are the strongest known risk factors for late-onset Alzheimer's disease (AD), but the mechanisms linking them to neuronal loss remain incompletely defined. Using multiomic data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), we propose a unified hypothesis in which two interdependent failure modes--saturation of microglial lipid flux capacity and disruption of the astrocyte--neuron lactate shuttle (ANLS) due to excess astrocytic membrane cholesterol--drive disease progression upstream of amyloid and tau pathology. Stratifying participants by cognitive score quartiles, we find consistent associations linking impaired lipid clearance, metabolic stress, and genetic variants regulating cholesterol handling. These processes appear to reinforce each other, resulting in accelerating neurodegeneration. Our hypothesis reframes AD as a systems-level collapse in metabolic coordination, rather than a purely linear pathological cascade. These insights emerged during the development of digital twin models for personalized interventions, highlighting the power of systems approaches to reveal hidden drivers of neurodegeneration.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper proposes that the saturation of microglial lipid flux capacity and disruption of the astrocyte-neuron lactate shuttle drive Alzheimer's disease progression. This research is relevant as it seeks to understand underlying mechanisms of neurodegeneration, which could inform strategies for addressing age-related cognitive decline.
Author of this paper? Send a correction.